Literature DB >> 33488667

Analysis of Wild Type LbCpf1 Protein, and PAM Recognition Variants, in a Cellular Context.

Ujin Shin1, Vincent Brondani1.   

Abstract

Nucleases used in genome engineering induce hydrolysis of DNA phosphate backbone in a sequence-specific manner. So far CRISPR-Cas, the RNA-guided nucleases, is the most advanced genome engineering system. The CRISPR nucleases allows recognition of a particular genomic sequence with two distinct molecular interactions: first, by direct interaction between the nuclease and the protospacer-adjacent motif, wherein discrete amino acids interact with DNA base pairs; and second, by hybridization of the guide RNA with the target DNA sequence. Here we report the application of the single strand annealing cellular assay to analyze and quantify nuclease activity of wild type and mutant CRISPR-Cpf1. Using this heterologous marker system based on GFP activity, we observed a comparable PAM recognition selectivity with the NGS analysis. The heterologous marker system has revealed that LbCpf1 is a more specific nuclease than AsCpf1 in a cellular context. We controlled the in vitro activity of the Cpf1 nuclease complexes expressed in mammalian cells and demonstrated that they are responsible of the DNA cleavage at the target site. In addition, we generated and tested LbCpf1 variants with several combinations of mutations at the PAM-recognition positions G532, K538 and Y542. Finally, we showed that the results of the in vitro DNA cleavage assay with the wild type and mutants LbCpf1 corroborate with the selection of 6TG resistant cells associated to the genomic disruption of hprt gene.
Copyright © 2021 Shin and Brondani.

Entities:  

Keywords:  Cpf1; PAM; genome engineering; selectivity; specificity

Year:  2021        PMID: 33488667      PMCID: PMC7817983          DOI: 10.3389/fgene.2020.571591

Source DB:  PubMed          Journal:  Front Genet        ISSN: 1664-8021            Impact factor:   4.599


  26 in total

1.  Targeting DNA double-strand breaks with TAL effector nucleases.

Authors:  Michelle Christian; Tomas Cermak; Erin L Doyle; Clarice Schmidt; Feng Zhang; Aaron Hummel; Adam J Bogdanove; Daniel F Voytas
Journal:  Genetics       Date:  2010-07-26       Impact factor: 4.562

2.  Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells.

Authors:  Daesik Kim; Jungeun Kim; Junho K Hur; Kyung Wook Been; Sun-Heui Yoon; Jin-Soo Kim
Journal:  Nat Biotechnol       Date:  2016-06-06       Impact factor: 54.908

3.  Structural Basis for the Altered PAM Recognition by Engineered CRISPR-Cpf1.

Authors:  Hiroshi Nishimasu; Takashi Yamano; Linyi Gao; Feng Zhang; Ryuichiro Ishitani; Osamu Nureki
Journal:  Mol Cell       Date:  2017-06-06       Impact factor: 17.970

4.  A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

Authors:  Martin Jinek; Krzysztof Chylinski; Ines Fonfara; Michael Hauer; Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2012-06-28       Impact factor: 47.728

5.  Cpf1 nucleases demonstrate robust activity to induce DNA modification by exploiting homology directed repair pathways in mammalian cells.

Authors:  Eszter Tóth; Nóra Weinhardt; Petra Bencsura; Krisztina Huszár; Péter I Kulcsár; András Tálas; Elfrieda Fodor; Ervin Welker
Journal:  Biol Direct       Date:  2016-09-14       Impact factor: 4.540

6.  Easy mammalian expression and crystallography of maltose-binding protein-fused human proteins.

Authors:  Marcel Bokhove; Hamed Sadat Al Hosseini; Takako Saito; Elisa Dioguardi; Katharina Gegenschatz-Schmid; Kaoru Nishimura; Isha Raj; Daniele de Sanctis; Ling Han; Luca Jovine
Journal:  J Struct Biol       Date:  2016-02-03       Impact factor: 2.867

7.  Engineered Cpf1 variants with altered PAM specificities.

Authors:  Linyi Gao; David B T Cox; Winston X Yan; John C Manteiga; Martin W Schneider; Takashi Yamano; Hiroshi Nishimasu; Osamu Nureki; Nicola Crosetto; Feng Zhang
Journal:  Nat Biotechnol       Date:  2017-06-05       Impact factor: 54.908

8.  Mb- and FnCpf1 nucleases are active in mammalian cells: activities and PAM preferences of four wild-type Cpf1 nucleases and of their altered PAM specificity variants.

Authors:  Eszter Tóth; Bernadett C Czene; Péter I Kulcsár; Sarah L Krausz; András Tálas; Antal Nyeste; Éva Varga; Krisztina Huszár; Nóra Weinhardt; Zoltán Ligeti; Adrienn É Borsy; Elfrieda Fodor; Ervin Welker
Journal:  Nucleic Acids Res       Date:  2018-11-02       Impact factor: 16.971

9.  Improved LbCas12a variants with altered PAM specificities further broaden the genome targeting range of Cas12a nucleases.

Authors:  Eszter Tóth; Éva Varga; Péter István Kulcsár; Virág Kocsis-Jutka; Sarah Laura Krausz; Antal Nyeste; Zsombor Welker; Krisztina Huszár; Zoltán Ligeti; András Tálas; Ervin Welker
Journal:  Nucleic Acids Res       Date:  2020-04-17       Impact factor: 16.971

10.  Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.

Authors:  Alexis C Komor; Yongjoo B Kim; Michael S Packer; John A Zuris; David R Liu
Journal:  Nature       Date:  2016-04-20       Impact factor: 49.962

View more
  1 in total

1.  Engineered Cas12a-Plus nuclease enables gene editing with enhanced activity and specificity.

Authors:  Hongxin Huang; Guanjie Huang; Zhihong Tan; Yongfei Hu; Lin Shan; Jiajian Zhou; Xin Zhang; Shufeng Ma; Weiqi Lv; Tao Huang; Yuchen Liu; Dong Wang; Xiaoyang Zhao; Ying Lin; Zhili Rong
Journal:  BMC Biol       Date:  2022-04-25       Impact factor: 7.364

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.